Tag » FDA
On August 18, 2015, the FDA decided to approve Addyi (ad-ee) – a new pill made to boost female libido. The decision follows a long campaign fighting the lack of sex enhancing drugs available to women. While Addyi is the first of its kind, men have access to several libido-inducing options including Viagra, Cialis, and Levitra. For years, the standard belief has been that only men lose their sex drive, but Addyi is a strike against this prehistoric view – the pill will (hopefully) allow doctors to begin to prescribe proper treatment for women with lower sexual desire. Read More
On Monday, the FDA approved the first pill created to prevent the transmission of HIV infections to those who are at high risk of exposure to the disease.  The medication, Truvada, is already used with other anti-retroviral drugs to treat HIV-positive patients.  Their recent approval means that the FDA now recommends Truvada as part of a comprehensive HIV prevention plan.  Patients still should, of course, practice safe sex (use condoms, avoid having sex with high-risk partners before getting tested for HIV, etc. Read More
Over-the-counter emergency contraception is now available for all! Today, the federal district court overturned the Obama administration’s age restrictions forbidding women under the age of 17 from purchasing over-the-counter emergency contraception without a prescription. Judge Edward Korman of the District Court of Eastern New York has directed the FDA to lift the ban within 30 days, describing the previous restriction as “a strong showing of bad faith and improper political influence,” and citing Plan B as “among the safest drugs sold over the counter. Read More
If you happen to be on a birth control pill manufactured by Pfizer, Inc., you should 1) probably pick up a pregnancy test after work, 2) also a box of condoms, 3) send Pfizer a bill for it, and 4) try not to cry. The manufacturer just voluntarily recalled one million packages of Lo/Ovral-28, Norgestrel/Ethinyl Estradiol after they noticed a “packaging error.” The packets should consist of three weeks of active pills and one week of sugar pills; but the last million might have contained incorrect amounts of each type of pill or are, in some cases, out of sequence. Read More
Reports coming out of the FDA don't look good for Flibanserin, the drug that's supposed to boost women's libidos. Interestingly enough, the problem seems to be that the little blue pill doesn't cause an increase in sexual desire, but in the number of "sexually satisfying events." Firstly, let me be proud to report that I can banish this weirdo euphemism in favor of the word ORGASM. Secondly, what? This is a problem...why? Before you get wound up about side effects, note–I'm not commenting on them. Read More
The FDA is deciding on whether or not to endorse the latest medication for lady problems: flibanserin. Dubbed the “pink Viagra,” this pill does what the little blue pill did for men in increasing their sex drive, supposedly. The medication alters the chemicals in a woman’s brain into thinking more sexual thoughts, and apparently the German manufacturers are not sure how they came upon this potential gold mine of a pill (an estimated $2 billion market in the US). Originally, flibanserin was designed to treat depression but failed. Read More